warfarin

Newer Anticoagulants May Reduce Intraocular BleedingThe risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.
How novel anticoagulants compare with warfarin for intraocular bleedingHow do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding? A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.
Prevent polypharmacy problemsPolypharmacy presents real problems—especially for older adults.
Regs, robbery responses among top “pharmacy gamechangers” for 2016
Regs, robbery responses among top “pharmacy gamechangers” for 2016The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.
Warfarin for CKD, aspirin for TIA, and what to do about ICHAnticoagulation briefs.
USPSTF updates recommendations for aspirin useThe guidelines, which update the group's 2007 and 2009 recommendations, are published in the "Annals of Internal Medicine."
Fall-related ICH incidence in elderly on warfarinA study of nearly 32,000 aging veterans revealed the unsuspected vulnerability of this population.
ICH volume smaller with DOACs than with warfarinA study of 344 patients with anticoagulant-associated ICH found that when data were adjusted for confounding factors, warfarin use remained independently associated with larger ICH volumes.
The expanding role of direct oral anticoagulants in the management of thromboembolic disease
The expanding role of direct oral anticoagulants in the management of thromboembolic diseaseThe goal of this program for pharmacists and technicians is to review the treatment of venous thromboembolism with the class of medications known as direct oral anticoagulants.
Study: Shorter hospital stays with XareltoUS hospitals using rivaroxaban (Xarelto, Janssen Pharmaceuticals) instead of warfarin (Coumadin, Bristol-Myers Squibb) to treat patients diagnosed with a venous thromboembolism (VTE) may save nearly $2,000 per patient and shorten a patient’s hospital stay by approximately 1.5 days, according to a new study.